GlassScriptPhysician profile
Michael A Pikos
NPI 1346239340
$2,976,196.96
in general payments reported to CMS, 2019-2025
14 companies · $145K in 2025
The $145K reported for 2025 was more than what 99% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $446K · 2020: $542K · 2021: $434K · 2022: $437K · 2023: $503K · 2024: $470K · 2025: $145K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $808K · Consulting Fee: $300K · Travel and Lodging: $7,139 · Food and Beverage: $3,085 · Education: $231 · Entertainment: $9.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $807,900.00 |
| Consulting Fee | $300,000.00 |
| Travel and Lodging | $7,138.69 |
| Food and Beverage | $3,085.11 |
| Education | $231.25 |
| Entertainment | $9.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohorizons Implant Systems INC. | $2,243,253.76 | 2019-2025 | Biohorizons, Biohorizons Dental Implants |
| Osteogenics Biomedical INC. | $319,281.80 | 2020-2023 | |
| Envista Holdings Corporation | $219,404.48 | 2024-2025 | |
| Carestream Dental, LLC | $154,750.00 | 2020-2021 | |
| Southern Implants North America INC | $35,431.97 | 2019-2023 | |
| Straumann USA LLC | $3,245.76 | 2020-2025 | |
| Zest Holdings, LLC | $279.70 | 2025 | |
| S.I.N. Implant System Ltda. | $199.22 | 2023 | |
| Neocis INC. | $121.60 | 2020 | |
| Salvin Dental Specialties, INC. | $106.33 | 2019 | |
| Orapharma, A Division of Bausch Health US, LLC | $74.18 | 2021-2025 | Arestin |
| Pacira Pharmaceuticals Incorporated | $16.81 | 2021 | |
| Sprintray INC | $15.75 | 2024 | Pro 2 3d Printer |
| Geistlich Pharma, North America, INC. | $15.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Pikos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.